ReShape Lifesciences Competitors and Similar CompaniesClear all

ReShape Lifesciences's competitors and similar companies include FIRE1, ElectroCore, BioCardia and SOLIUS.

	ReShape Lifesciences ReShape Lifesciences, a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders.	FIRE1 FIRE1 focuses on developing novel remote monitoring devices.	ElectroCore ElectroCore develops neuromodulation therapies for the non-invasive treatment of diseases and disorders.	BioCardia BioCardia is a clinical-stage regenerative medicine company.	SOLIUS SOLIUS (also known as Benesol) is a company that develops medical light therapy solutions.
Founding Date	Founding Date 2002	Founding Date N/A	Founding Date 2005	Founding Date 2002	Founding Date 2011
Type	Type Public	Type Private	Type Public	Type Public	Type Private
Tags	Tags Healthcare biotech medical devices therapy	Tags Healthcare biotech medical devices therapy	Tags Healthcare biotech medical devices therapy	Tags Healthcare biotech medical devices therapy	Tags Healthcare biotech medical devices therapy
Locations	Locations San Clemente, US HQ San Clemente, US	Locations Dublin, IE HQ Dublin, IE	Locations Rockaway, US HQ Parksville, CA Geretsried, DE Hamburg, DE Yeadon, GB Bernards, US	Locations San Carlos, US HQ	Locations Bainbridge Island, US HQ
Employees	Employees 4348% decrease	Employees 838% increase	Employees 5144% decrease	Employees 2713% increase	Employees 31
Valuation ($)	Valuation ($) 3 m	Valuation ($) N/A	Valuation ($) 71.2 m	Valuation ($) 8.5 m	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $11.3m (FY, 2020)	Revenue (est.) N/A	Revenue (est.) $32m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods $5m (FY, 2020)	Cost of goods N/A	Cost of goods $4.2m (FY, 2025)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit $6.3m (FY, 2020)	Gross profit N/A	Gross profit $27.8m (FY, 2025)	Gross profit N/A	Gross profit N/A
Net income	Net income ($21.6m) (FY, 2020)	Net income N/A	Net income ($14m) (FY, 2025)	Net income ($8.2m) (FY, 2025)	Net income N/A
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 7.5m	Total funding raised $ 127m	Total funding raised N/A	Total funding raised N/A